[1]黄优.探讨蛋白酶体功能障碍对散发性帕金森病发病机制的影响[J].卒中与神经疾病杂志,2017,24(05):455-457.[doi:10.3969/j.issn.1007-0478.2017.05.019]
点击复制

探讨蛋白酶体功能障碍对散发性帕金森病发病机制的影响()
分享到:

《卒中与神经疾病》杂志[ISSN:1007-0478/CN:42-1402/R]

卷:
第24卷
期数:
2017年05期
页码:
455-457
栏目:
论 著
出版日期:
2017-10-26

文章信息/Info

文章编号:
1007-0478(2017)05-0455-03
作者:
黄优
572000 海南省第三人民医院神经内科
关键词:
蛋白酶体功能障碍 α-突触核蛋白(α-Syn)散发性帕金森 发病机制
分类号:
R742.5
DOI:
10.3969/j.issn.1007-0478.2017.05.019
摘要:
目的 探讨蛋白酶体功能障碍对散发性帕金森病的发病机制。方法 收集本院2013年7月~2015年7月病例,将存在蛋白酶体功能障碍的帕金森病患者50例作为观察组,未存在蛋白酶体功能障碍的帕金森病患者50例作为对照组,观察2组患者的行为学改变情况,通过RT-PCR、Western blotting分子生物学方法检测患者血液中α-突触核蛋白(α-Syn)表达水平。结果 观察组患者血清的α-突触核蛋白表达水平显著高于对照组(P<0.05)。结论 蛋白酶体功能障碍可能导致散发性帕金森病患者血液中α-突触核蛋白(α-Syn)水平升高,考虑该因素可能是散发性帕金森疾病的危险因素。

参考文献/References:

[1] MiwaH,KuboT,Suzuki A,et al.Retrograde dopam inergic neuron degeneration following intrastriatal proteasome inhibition[J].Neurosci Lett,2014,380(1/2):93-98.
[2] W IW,Haass C.Mitochondrial dysfunction in Parkinson's disease[J].Biochim Biophys Acta,2010,1802(1):29-44.
[3] A NA.Mitochondrial diseases[J].Lancet,2016,2(379):16081.
[4] B LB.Neural and immune mechanisms in the pathogenesis ofParkinson's disease[J].Journal of Neuroimmune Pharmacology,2013,8(1):189-201.
[5] 陈生弟,乐卫东,陈先文,等.帕金森病[M].北京:人民卫生出版社,2006.
[6] 李兴安,张应玖,常明,等.散发性帕金森病蛋白酶体功能障碍及其所致的路易(小)体形成[J].生物化学与生物物理进展,2008,35(5):502-511.
[7] H IH,Vyas S,Hunot S.Neuroinflammation in parkinson's disease[J].Parkinsonism Relat Disord,2012,18(Suppl):210-212.
[8] K AK,Jin H,Mehrotra S,et al.Novel cell death signaling pathways in neurotoxicity models of dopaminergic degeneration:relevance to oxidative stress and neuroinflammation in Parkinson's disease[J].Neurotoxicology,2010,31(5):555-561.
[9] Y VY.Neuroinflammation inflammatory brain drain[J].Nat Rev Immunol,2013,13(2):69.
[10] M IM,Tentler JJ,Smith PG,et al.Role of ubiquitin ligases and the proteasome in oncogenesis:novel targets for anticancer therapies[J].Journal of Clinical Oncology,2013,31(9):1231-1238.
[11] E RE,Avvakumov G,Tong J,et al.A strategy for modulation of enzymes in the ubiquitin system[J].Science,2013,339(6119):590-595.
[12] C OC,Hatchwell L,Verrills N,et al.The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity[J].Nat Med,2013,19(2):232-237.
[13] Y OY.Molecular dissection of autophagy two ubiquitin-like systems[J].Nature Review,2001,2(3):211-216.
[14] Y AY,Zhao D,Khan SH,et al.Role of autophagy in prion protein-induced neurodegenerative diseases[J].Acta Biochim Biophys Sin(Shanghai),2013,45(6):494-502.
[15] C HC,Ryter SW,Levine B.Autophagy in human health and disease[J].N Engl J Med,2013,368(7):651-662.
[16] R UR,Marino G,Kroemer G.Autophagy and aging[J].Cell,2011,146(5):682-695.
[17] O RO,Sheng HK,Tasset I,et al.Interplay of LRRK2 with chaperone-mediated autophagy[J].Nature Neuroscience,2013,16(4):394-406.

更新日期/Last Update: 2017-10-20